DAVID GITONGA NYAMU
BPharm, MPharm, MBA, Implementation Science Fellow, PhD (UoN)
P.O.BOX 1003-00200 • NAIROBI • KENYA
PHONE 254- 722 403 671 (CELL),
E-mail:
[email protected] or
[email protected]
1. PERSONAL INFORMATION
Current Employer: University of Nairobi
Position: Senior Lecturer, Department of Pharmacology Clinical Pharmacy and Pharmacy Practice
Section Head, Clinical Pharmacy
Qualifications: BPharm, MPharm, MBA, ISF, PhD
Specialization: Clinical Pharmacy/Researcher
Nationality: Kenyan
Gender: Male
2. EDUCATION BACKGROUND
2.0 2023 Kenyatta University MBA
2.1 2019 University of Nairobi PhD
2.2 2016 University of Nairobi Implementation Science Fellow
2.3 2008 University of Nairobi MPharm
2.4 1998 University of Nairobi BPharm
3. POSITIONS AND WORKING EXPERIENCE
ADMINISTRATION AND MANAGEMENT
3.1.1 Current: July 2022- Section Head, Clinical Pharmacy
3.1.2 Sept 2020-June 2022 Chairman, Department of Pharmaceutics & Pharmacy Practice
3.1.3 2020 July: Member, Editorial Board, PJK
3.1.4 2018 December – 2021 Member, CPDTC, PPB
3.1.5 2017 January-To date: Co-ordinator, BPharm V and MPharm II Clinical Pharmacy Course
3.1.6 2016 June- 2018: Co-ordinator, EAKI, Renal Pharmacy Preceptorship
3.1.7 2015 January-To date: Member, Education and Publication Committee, PSK
3.1.8 2014-2017 Various Dates: Acting Chair, Department of Pharmaceutics & Pharmacy Practice
3.1.9 2013- 2018: Chairman, Department of Pharmaceutics & Pharmacy Practice Welfare Committee
3.1.10 2012 January – 2016 Dec: Co-ordinator, Clinical Pharmacy Programme, UoN
3.1.11 2011-Date: Vice-Chair, Fourth term Committee
3.1.12 2012- To date: Patron, Kambandi Health Centre
3.1.13 2011-Date: Team Leader, Hospital Rotation for BPharm IV
3.1.14 2004-2005: Training Manager, MEDS
TEACHING
3.1.15 2019-Current position: Senior Lecturer
3.1.16 2011 –2019: Lecturer
3.1.17 2007 – 2011: Tutorial Fellow
3.1.18 1994: High School Teacher
MEDICAL/PHARMACEUTICAL PRACTICE
3.1.19 1999 –2004 Chief Pharmacist, Lemuma Pharmacy Ltd.
3.1.20 1998-1999 Pharmacist Intern
4. RESEARCH
4.1 AREAS OF INTEREST
4.1.1 Anticoagulation and Thromboembolic Disorders
4.1.2 Management of cardiovascular and endocrine disorders
4.1.3 Medication Therapy Management of Diseases
4.1.4 Pharmacotherapy of Infectious Diseases
4.1.5 Cancer Management
4.1.6 Strategic Management
4.2 ONGOING PROJECTS
1. Pattern and Determinants of Anticoagulation among Kenyan patients with Cancer
2. Correlates of Heart failure management and outcomes in Kenya.
3. Drug related problems in patients with both cardiovascular disorders and Diabetes Mellitus.
4. Medication related problems among patients with gastrointestinal cancers
4.3 SUCCESSFUL GRANTS
1 Clinical Predictors and Genetic Determinants of Response to Warfarin Therapy in Kenyan Patients
Source: National Commission for Science Technology & Innovation (NACOSTI)
Amount: KES 1000,000
2 Management Of Adult Cancer Patients With Neutropenia Using Granulocyte Colony Stimulating Factors At Kenyatta National Hospital
Source: Kenyatta National Hospital
Amount: KES 400,000
Grant Reference number: KNH/R&P/23J/98/9
3 Outcomes of a Pharmacist-Led Anticoagulation Education Program among Patients on Long-Term Warfarin Therapy in a Kenyan Referral Hospital.
Source: Kenyatta National Hospital
Amount: KES 400,000
4 Metformin’s effectiveness in preventing prednisone-induced hyperglycemia in hematological cancers. Journal of Oncology Pharmacy Practice
Source: Kenyatta National Hospital
Amount: KES 400,000
5 Prevalence and Correlates of Neurocognitive Disorders among HIV Patients on Antiretroviral Therapy at a Kenyan Hospital.
Source: Kenyatta National Hospital
Amount: KES 400,000
5. SELECTED PEER REVIEWED JOURNAL PUBLICATIONS
A. Anticoagulation
5.1 Sakina I. Mamdani, David G. Nyamu and Tom B. Menge(2020). Outcomes of a Pharmacist-Led Anticoagulation Education Program among Patients on Long-Term Warfarin Therapy in a Kenyan Referral Hospital. wjpmr, 2020,6(7), 177-183.
5.2 David Gitonga Nyamu, Anastasia Nkatha Guantai, George Oyamo Osanjo, Brian Godman & Eleni Aklillu (2020). Profiles of patients on warfarin anticoagulation therapy in a leading tertiary referral hospital in Kenya; findings and implications for Kenya, Expert Review of Cardiovascular Therapy, 18:3, 165-173, DOI: 10.1080/14779072.2020.1734452. To link to this article: https://doi.org/10.1080/14779072.2020.1734452
5.3 Karuri, S., Nyamu, D., Opanga, S., Menge, T., 2019. Factors Associated with Time in Therapeutic Range among Patients on Oral Anticoagulation Therapy in a Tertiary Teaching and Referral Hospital in Kenya. East Cent. Afr. J. Pharm. Sci. 22, 85–95.
5.4 Nyamu, D.G.,Guantai, A.N., Osanjo, G.O., Aklillu, E., 2019. Trends of anticoagulation control among adult outpatients on long-term Warfarin therapy in a Tertiary Teaching and Referral Hospital in Kenya. East Afr. Med. J. 95 (7): 1705–1709.
5.5 Nyamu, D.G., Guantai, A.N., Osanjo, Aklillu E. , Tele A.K.(2019). P
Leave your rating